Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

Mise à jour : Il y a 4 ans
Référence : NCT01356602

Femme et Homme

Extrait

This study assessed the safety and efficacy of canakinumab pre-filled syringes in comparison to triamcinolone acetonide 40 mg and canakinumab lyophilizate in patients that have frequent flares of acute gouty arthritis.


Critère d'inclusion

  • Acute Gouty Arthritis


Liens